Liminatus Pharma, Inc.
LIMN
$0.65
-$0.06-8.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.86% | -- | -- | 19.15% | -- |
| Total Receivables | -- | -- | -- | 17.63% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.84% | -- | -- | 56.00% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 25.31% | -- |
| Total Current Assets | -32.48% | -- | -- | 20.48% | -- |
|
|
|||||
| Total Current Assets | -32.48% | -- | -- | 20.48% | -- |
| Net Property, Plant & Equipment | 6,300.00% | -- | -- | 0.00% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -- | -- | 0.00% | -- |
| Total Assets | -29.67% | -- | -- | 19.91% | -- |
|
|
|||||
| Total Accounts Payable | 29.47% | -- | -- | 26.62% | -- |
| Total Accrued Expenses | 11.52% | 14,972.73% | -99.96% | 3.54% | -- |
| Short-term Debt | 0.00% | -- | -- | 3.63% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -92.00% | -- | -- | 4.84% | -- |
| Total Other Current Liabilities | -92.00% | -- | -- | 4.84% | -- |
| Total Current Liabilities | -72.76% | 955,872.73% | -100.00% | 4.77% | -- |
|
|
|||||
| Total Current Liabilities | -72.76% | 955,872.73% | -100.00% | 4.77% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 0.00% | -- | -- | 3.63% | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -38.35% | -- | -- | -- | -- |
| Total Liabilities | -72.12% | 974,100.00% | -100.00% | 4.77% | -- |
|
|
|||||
| Common Stock & APIC | 44.76% | -- | -100.00% | 0.00% | -- |
| Retained Earnings | -6.31% | -2,625,309.09% | 100.00% | -0.81% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 81.31% | -800,572.73% | 99.99% | -1.20% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 81.31% | -800,572.73% | 99.99% | -1.20% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 81.31% | -800,572.73% | 99.99% | -1.20% | -- |
|
|
|||||